Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Tepmetko
Pharma
AZ, HutchMed get China nod for Orpathys for rare type of NSCLC
With Orpathys, AZ and HutchMed are the first in China to receive approval for a treatment against a rare form of NSCLC.
Kevin Dunleavy
Jun 23, 2021 11:17am
Merck KGaA's new chief rejigs its U.S. management team
May 18, 2021 11:39am
Merck KGaA matches Novartis with FDA green light for Tepmetko
Feb 4, 2021 12:09pm
Chloroquine, BeiGene, Merck KGaA and more—FiercePharmaAsia
Mar 27, 2020 10:56am
Merck KGaA bags targeted lung cancer nod for Tepmetko in Japan
Mar 25, 2020 11:15am
